# Frost & Sullivan Awards WuXi AppTec 2026 Global Company of the Year for CRDMO Leadership

> Frost & Sullivan named WuXi AppTec its 2026 Global Company of the Year in CRDMO, citing 741 regulatory inspections completed in 2025.

- Published: 2026-10-20T00:26:15+00:00
- Section: Business
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-20/frost-sullivan-wuxi-apptec-company-of-the-year
- Source: [Newswire](https://www.newswire.ca/news-releases/frost-amp-sullivan-awards-wuxi-apptec-with-2026-global-company-of-the-year-recognition-for-crdmo-leadership-828617213.html)

## Key takeaways

- Frost & Sullivan awarded WuXi AppTec the 2026 Global Company of the Year Recognition in the CRDMO industry.
- WuXi AppTec completed 741 regulatory inspections and customer audits in 2025 with zero critical findings.
- Frost & Sullivan benchmarks companies on strategy effectiveness and strategy execution, and WuXi AppTec excelled in both.

[Frost & Sullivan](https://akta.pro/company-profiles/0002iew/frost-sullivan) has awarded [WuXi AppTec](https://akta.pro/company-profiles/0000ca7/wuxi-apptec) the 2026 Global Company of the Year Recognition in the CRDMO industry, citing integrated capabilities, global capacity and customer-centric innovation. The recognition was announced by [Newswire](https://www.newswire.ca/news-releases/frost-amp-sullivan-awards-wuxi-apptec-with-2026-global-company-of-the-year-recognition-for-crdmo-leadership-828617213.html). WuXi AppTec is a contract research, development and manufacturing organization serving pharmaceutical and life sciences companies.

## How Frost & Sullivan Benchmarked WuXi AppTec

Frost & Sullivan evaluates companies through a benchmarking process across two core dimensions: strategy effectiveness and strategy execution. WuXi AppTec excelled in both, according to the recognition. Its integrated CRDMO model offers broad capabilities, global manufacturing capacity and quality management across the full drug development cycle, supported by a network across Asia, Europe and North America.

"WuXi AppTec distinguishes itself through its strong focus on evolving customer needs," said Unmesh Lal, Vice President, Healthcare and Life Sciences at Frost & Sullivan. "Its commitment to customer success reinforces its position as a trusted partner to biopharmaceutical innovators worldwide."

"We are honored that Frost & Sullivan has once again recognized what our teams deliver every day for customers," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "As a dedicated enabler of the pharmaceutical industry, we will remain committed to our CRDMO strategy, helping customers bring life-changing therapies to market faster and benefit patients around the world."

WuXi AppTec invests in development and manufacturing capabilities for emerging therapeutic modalities and advanced technologies, including oligonucleotides, peptides and related conjugated medicines. In 2025, the company completed 741 regulatory inspections and customer audits with zero critical findings. Its One Global Quality System supports standardized governance and quality practices across operating locations.

## Frost & Sullivan's Advisory Scale

Frost & Sullivan is a growth advisory and analytics firm founded in 1961 and headquartered in San Antonio, according to akta.pro [company records](https://akta.pro/company-data). The firm operates 45 offices globally with more than 1,200 experts, growth advisors and visionaries, and reports 60+ years of proven expertise across industries. Its leadership includes Chief Executive Officer Darrell Huntsman and Chairman David Frigstad.

## Frost & Sullivan's Recent Recognition Cycle

Frost & Sullivan named LevelBlue the 2026 Global Company of the Year in Managed Security Services in October 2026, according to PR Newswire. Kaspersky was named the 2026 Global APT Intelligence & Threat Attribution Company of the Year in October 2026, according to Lankatalks. Singtel Digital InfraCo received the 2026 Southeast Asia Transformational Innovation Leadership Recognition for AI infrastructure in October 2026, according to Newswire.

## WuXi AppTec's Next Steps

WuXi AppTec said it will continue its CRDMO strategy to accelerate drug development. The company's [own announcement](https://www.wuxiapptec.com) describes its work with partners across 30+ countries.

## Companies in this story

- [Frost & Sullivan company profile](https://akta.pro/company-profiles/0002iew/frost-sullivan) · website: http://www.frost.com
- [WuXi AppTec company profile](https://akta.pro/company-profiles/0000ca7/wuxi-apptec) · website: https://www.wuxiapptec.com

---
News for Agent · https://newsforagent.com/llms.txt